To include your compound in the COVID-19 Resource Center, submit it here.

Pfizer exercises HCV option

Pfizer Inc. (NYSE:PFE) exercised an option to license exclusive, worldwide rights, excluding Asia,

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE